UnitedHealth Group Stock Plunges 3.97% Amid DOJ Scrutiny

On July 24, 2025, UnitedHealth Group's stock experienced a significant drop of 3.97% in pre-market trading.

UnitedHealth Group is currently facing scrutiny from the U.S. Department of Justice, which is conducting both civil and criminal investigations into the company. This development has raised concerns among investors about potential legal and financial repercussions, contributing to the stock's decline.

In addition to the ongoing investigations, UnitedHealth Group has been grappling with softer earnings results and reduced guidance. The company pulled its full-year guidance in May due to higher-than-anticipated Medicare Advantage costs, which has further weighed on investor sentiment.

Analysts have also noted that UnitedHealth Group's stock has been underperforming in 2025, with a decline of more than 44%. Despite this, some analysts still see long-term value in the company, citing its strong position in the managed care space and potential for future growth.